(Q42462263)

1 November 2017

Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling (English)

1 reference

1 November 2017

0 references

Faryad Darabi Sahneh

1

1 reference

1 November 2017

Caterina M Scoglio

series ordinal

2

1 reference

1 November 2017

Nancy A Monteiro-Riviere

series ordinal

3

1 reference

1 November 2017

Jim E Riviere

series ordinal

4

1 reference

1 November 2017

17 July 2014

1 reference

1 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Nanomedicine

1 reference

1 November 2017

10

1 reference

1 November 2017

1

1 reference

1 November 2017

25-33

1 reference

The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century

1 November 2017

1 reference

Biomolecular coronas provide the biological identity of nanosized materials

21 January 2018

1 reference

Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?

21 January 2018

1 reference

Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells

21 January 2018

1 reference

Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells.

21 January 2018

1 reference

Facing the truth about nanotechnology in drug delivery

21 January 2018

1 reference

Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic?

21 January 2018

1 reference

Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle

21 January 2018

1 reference

Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots

21 January 2018

1 reference

Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective

21 January 2018

1 reference

Time concepts in physics, biology, and pharmacokinetics

21 January 2018

1 reference

Time evolution of the nanoparticle protein corona.

21 January 2018

1 reference

An index for characterization of nanomaterials in biological systems.

21 January 2018

1 reference

Modeling the time evolution of the nanoparticle-protein corona in a body fluid

21 January 2018

1 reference

Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations

21 January 2018

1 reference

Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.

21 January 2018

1 reference

Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity

21 January 2018

1 reference

Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

21 January 2018

1 reference

The Evolution of the Protein Corona around Nanoparticles: A Test Study

21 January 2018

1 reference

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

21 January 2018

1 reference

Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model

21 January 2018

1 reference

In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.

21 January 2018

1 reference

Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.14.60

1 reference

1 November 2017

1 reference